News for 'FDA'

Gutkha sale banned in Maharashtra

Gutkha sale banned in Maharashtra

Rediff.com30 Jan 2005

The move comes after a FDA notice to gutkha manufacturers to mention the contents of their product on the cover.

Is Dilip Shanghvi's big bet worth the risk?

Is Dilip Shanghvi's big bet worth the risk?

Rediff.com22 Apr 2014

For Sun Pharma, it is an astute purchase that it hopes will not only boost its position in India but also globally.

3 sectors to watch for as economic growth picks up

3 sectors to watch for as economic growth picks up

Rediff.com12 Jan 2021

Overall, the credit profiles of players will be supported by healthy balance sheets and liquidity. Prudence in capital and development expenditure, efficient working-capital management, and recent equity raising will help sustain credit metrics in FY22.

US regulator fast-tracks approval for Wockhardt drugs

US regulator fast-tracks approval for Wockhardt drugs

Rediff.com1 Sep 2014

These drugs will be entering in their global Phase -3 clinical trials early next year.

'No one is saying the vaccine is unsafe'

'No one is saying the vaccine is unsafe'

Rediff.com8 Jan 2021

'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'

Why Daiichi is taking Malvinder Singh to court

Why Daiichi is taking Malvinder Singh to court

Rediff.com27 Nov 2013

The Japanese company alleges the earlier Ranbaxy promoters withheld crucial information when they sold the company in 2008.

Why Wockhardt's Waluj facility is under lens

Why Wockhardt's Waluj facility is under lens

Rediff.com18 Nov 2013

After recovering from issues such as defaults on foreign currency convertible bonds and piling debts, pharmaceutical major Wockhardt has been on the slow lane through the last six months, following warnings from global regulators such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare Products Regulatory Agency.

Dard Anek, ilaj ek: NaMo pain balm

Dard Anek, ilaj ek: NaMo pain balm

Rediff.com8 Apr 2014

The pain relieving balm is made available at more than 1,000 retail stores in 75 different cities in 12 states in India

Pesticides found in Pepsi samples in Maharashtra

Pesticides found in Pepsi samples in Maharashtra

Rediff.com22 Aug 2003

The tests, according to the report, showed that Pepsi products from its plant in Khalapur in Raigad district contained 0.6 mg of lindane, which is above the permissible limits.

Religare's banking bid under Ranbaxy cloud

Religare's banking bid under Ranbaxy cloud

Rediff.com1 Jun 2013

Singh brothers might be stopped by 'fit & proper' hurdle due to US drug norm violations; firm says confident of qualifying.

Wasn't just a flu, US was attacked: Trump on COVID-19

Wasn't just a flu, US was attacked: Trump on COVID-19

Rediff.com23 Apr 2020

'We built it in the last three years and then one day, they came and they said you have to close it'

Clean chit for J&J's baby shampoo

Clean chit for J&J's baby shampoo

Rediff.com10 Jun 2019

The outcome reaffirms the company's own testing and the long-standing assurance it gave that its baby shampoo does not contain formaldehyde or any formaldehyde-releasing ingredients, J&J said.

Nestle pasta found unsafe, lead beyond permissible limit

Nestle pasta found unsafe, lead beyond permissible limit

Rediff.com27 Nov 2015

After Maggi, the sample of macroni pasta was taken from Mau and sent to National Food Analysis Laboratory.

Don't need to sell assets, can pay fine: Ranbaxy brothers

Don't need to sell assets, can pay fine: Ranbaxy brothers

Rediff.com25 May 2016

In 2013, Daiichi had launched the arbitration proceedings in Singapore.

These smart devices will make you healthier!

These smart devices will make you healthier!

Rediff.com30 Dec 2019

Amrita Singh scours the market for the smartest health devices going.

Oxford jabs effective against severe Covid: US trial

Oxford jabs effective against severe Covid: US trial

Rediff.com22 Mar 2021

The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.

Maharashtra drug body cracks down on misleading ads

Maharashtra drug body cracks down on misleading ads

Rediff.com7 May 2012

The Maharashtra Food and Drugs Administration has initiated action against manufacturers of medicines and instruments, newspapers, TV channels and cable operators making outrageous claims through advertisements.

Oxford vaccine doing 'everything expected': Study

Oxford vaccine doing 'everything expected': Study

Rediff.com22 Oct 2020

A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.

India could be 'efficacy test' for TB drug okayed by US

India could be 'efficacy test' for TB drug okayed by US

Rediff.com17 Mar 2013

There are also lingering concerns over the culture of misuse of pharmaceutical products in India, which has, in the past, led to other drugs becoming increasingly ineffective.

Mice, roaches found in food served on US airlines

Mice, roaches found in food served on US airlines

Rediff.com21 Nov 2012

Through a Freedom of Information Act request, the Show '20/20' obtained lists of recent health violation records from the FDA, the agency in charge of inspecting airlines and their outside food caterers.

Ranbaxy expects guidance on Dewas unit by December

Ranbaxy expects guidance on Dewas unit by December

Rediff.com12 Nov 2012

Work to begin after that on corrective measures to meet US regulator's requirements.

New rules for Indian generic drug makers

New rules for Indian generic drug makers

Rediff.com29 Oct 2012

Regulator says fee would enable it to quicken approval process.

Wait for Indian generic launches gets longer

Wait for Indian generic launches gets longer

Rediff.com29 Oct 2012

USFDA has extended the timeline for granting tentative approval to generic drug applications filed under Para IV of its rules by 10 months.

Pharma stocks could rise another 15-20%

Pharma stocks could rise another 15-20%

Rediff.com28 Jul 2014

Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.

Indian majors lead race for US drug ingredient market

Indian majors lead race for US drug ingredient market

Rediff.com30 Jan 2013

In 2012, drugs worth $35 billion went off-patent in the US, while the market size of drugs which will see patent expiry in 2013 will halve to $17 billion.

Cancer, cholesterol, heart health: Why you must eat NUTS

Cancer, cholesterol, heart health: Why you must eat NUTS

Rediff.com11 Oct 2012

They are tasty, they are calorie-rich, and they are good for your heart. Doesn't that sound contradictory and too good to be true? Well, think again. We're talking about nuts!

The dirty dozen: THESE foods are best bought organic

The dirty dozen: THESE foods are best bought organic

Rediff.com5 Jun 2012

Research shows that the following foods are the most pesticide-retentive. So rather than expose yourself to them, here's why you should strictly stick to the organic options.

US drug regulator to inspect Aurobindo facilities

US drug regulator to inspect Aurobindo facilities

Rediff.com16 Aug 2012

Import alert on unit-6 facility might be lifted by FDA by Sept.

ICMR plans to scale-up testing capacity to 1 lakh/day

ICMR plans to scale-up testing capacity to 1 lakh/day

Rediff.com6 Apr 2020

The ICMR has approved over 200 labs (both public and private) for COVID-19 testing through-PCR machines.

US allows 'game-changer' saliva-based Covid test

US allows 'game-changer' saliva-based Covid test

Rediff.com16 Aug 2020

The new test it will enable rapid testing amongst more people easily.

How India's pharma growth story fizzled out

How India's pharma growth story fizzled out

Rediff.com5 Jul 2017

Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.

Can Ranbaxy recover from its US debacle?

Can Ranbaxy recover from its US debacle?

Rediff.com2 Feb 2012

USFDA consent decree reveals that firm will have to forego huge short-term opportunities for its generics.

Moderna says its COVID-19 vaccine is 94.5% effective

Moderna says its COVID-19 vaccine is 94.5% effective

Rediff.com16 Nov 2020

Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.

Cipla recalls asthma drugs in US

Cipla recalls asthma drugs in US

Rediff.com21 May 2015

Cipla is recalling the drug for failed impurities and degradation specifications.

Ranbaxy Lipitor rights: Mylan challenge dismissed

Ranbaxy Lipitor rights: Mylan challenge dismissed

Rediff.com4 May 2011

Mylan had sued the United States Food and Drugs Administration for providing the exclusive right to Ranbaxy, alleging the permission was given on the basis of 'falsified data'.

Using blood banks in Maharashtra to cost more

Using blood banks in Maharashtra to cost more

Rediff.com4 Mar 2012

At present, the service charge for one unit (bag) of blood is Rs 850.

Covid-19: How the testing infrastructure is struggling

Covid-19: How the testing infrastructure is struggling

Rediff.com25 Mar 2020

'India is too large a place to have just 10 labs performing these Covid-19 tests.'

Indian companies not singled out for inspections: USFDA

Indian companies not singled out for inspections: USFDA

Rediff.com18 Mar 2015

A global policy would reward firms which strive for higher quality.

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.